Paper39754657
APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway.
Du S and 7 others. Biochem Genet, 2026. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway. Papers, record 39754657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39754657
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apolipoproteins M | Major topic |
| Liver Neoplasms | Major topic |
| Glycolysis | Major topic |
| Hexokinase | Major topic |
| Receptors, Notch | Major topic |
| Humans | |
| Signal Transduction | |
| Gene Expression Regulation, Neoplastic | |
| Cell Line, Tumor | |
| Hep G2 Cells | |
| Glucose |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KJ2020A0612 | Scientific Research Foundation of Education Department of Anhui Province of China | PubMed | ||
| 202310368006 | National College Students Innovation and Entrepreneurship Training Program | PubMed | ||
| S202310368096 | Anhui college students innovation and entrepreneurship training program project | PubMed | ||
| LAB202202 | Anhui Provincial Key Laboratory of Bioactive Macromolecules Research Independent Research Project | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,149,930 | ApoM is an important potential protective factor in the pathogenesis of primary liver cancer. | J Cancer | 2021 | https://conductscience.org/library/papers/34149930 | PubMed |
| 2 | 37,236,409 | Therapeutic strategies targeting metabolic characteristics of cancer cells. | Crit Rev Oncol Hematol | 2023 | https://conductscience.org/library/papers/37236409 | PubMed |
| 3 | 35,158,779 | Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158779 | PubMed |
| 4 | 35,289,308 | Targeting the vasculature in cardiometabolic disease. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35289308 | PubMed |
| 5 | 38,572,751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 6 | 36,859,310 | m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. | Mol Cancer | 2023 | https://conductscience.org/library/papers/36859310 | PubMed |
| 7 | 35,078,134 | UALCAN: An update to the integrated cancer data analysis platform. | Neoplasia | 2022 | https://conductscience.org/library/papers/35078134 | PubMed |
| 8 | 36,911,798 | The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases. | Immune Netw | 2023 | https://conductscience.org/library/papers/36911798 | PubMed |
| 9 | 35,682,918 | Roles of Notch Signaling in the Tumor Microenvironment. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682918 | PubMed |
| 10 | 32,273,439 | Metabolic reprogramming and cancer progression. | Science | 2020 | https://conductscience.org/library/papers/32273439 | PubMed |
| 11 | 32,872,164 | Fatty Acid Synthase: An Emerging Target in Cancer. | Molecules | 2020 | https://conductscience.org/library/papers/32872164 | PubMed |
| 12 | 32,221,968 | The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis. | Hepatology | 2021 | https://conductscience.org/library/papers/32221968 | PubMed |
| 13 | 35,144,601 | Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/35144601 | PubMed |
| 14 | 35,022,204 | Hallmarks of Cancer: New Dimensions. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35022204 | PubMed |
| 15 | 21,376,230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 30,610,087 | Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis. | Cancer Res | 2019 | https://conductscience.org/library/papers/30610087 | PubMed |
| 17 | 33,194,645 | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers. | Front Oncol | 2020 | https://conductscience.org/library/papers/33194645 | PubMed |
| 18 | 36,672,360 | Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672360 | PubMed |
| 19 | 32,863,941 | DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. | Theranostics | 2020 | https://conductscience.org/library/papers/32863941 | PubMed |
| 20 | 39,630,888 | Boosting 1H and 13C NMR signals by orders of magnitude on a bench. | Sci Adv | 2024 | https://conductscience.org/library/papers/39630888 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,455,107 | Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic Mediators. | JACC CardioOncol | 2026 | https://conductscience.org/library/papers/42455107 | PubMed |
| 42,161,914 | Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42161914 | PubMed |
| 41,719,166 | ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation. | Sci Prog | 2026 | https://conductscience.org/library/papers/41719166 | PubMed |
| 41,430,109 | Molecular regulatory network of glycolytic reprogramming in hepatocellular carcinoma and its clinical implications. | Biol Proced Online | 2025 | https://conductscience.org/library/papers/41430109 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOM | 55,937 | PubTator's text mining | https://conductscience.org/library/genes/55937 | NCBI Gene |
| HK2 | 3,099 | PubTator's text mining | https://conductscience.org/library/genes/3099 | NCBI Gene |
| LDHA | 3,939 | PubTator's text mining | https://conductscience.org/library/genes/3939 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39754657
GET https://conductscience.org/api/papers/v1/39754657/references?page=2